News Tag: 2023 newsletters

Megan Mullins, PhD, NRG Cancer Care Delivery Researcher, Examines Health Equity Issues in Latest Publication

Read More

NRG-BR009 (“OFSET”): A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression and Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score of ≤ 25

Read More

RTOG 1308 Accrual Completion: First Phase III NCTN Clinical Trial Comparing Photon Versus Proton Therapy to Meet Accrual Target

Read More

FORTE Study Update – September 2023

Read More

Reminder to review CTEP IAM account and NRG roster status

Read More

Secondary Analysis of NRG Oncology-RTOG 0617 Presented at IASLC 2023

Read More

FORTE Study Update – August 2023

Read More